Literature DB >> 208968

Cell-mediated immunity assayed by 51Cr release test in mice infected with mouse adenovirus.

T Inada, H Uetake.   

Abstract

Immune spleen cells (ISC) from mice immunized with a sublethal dose of mouse adenovirus (M-Ad) were shown by the 51Cr release test to be cytotoxic to target mouse embryonic cells or lymphoid cells infected with M-Ad. The number of ISC required for release of statistically significant amounts of 51Cr from target cells varied from one sample to another, ranging from 5 to greater than or equal to 30 ISC per target cell. When 24-h-infected mouse embryonic cells were used as targets, the release of 51Cr became evident in 6 h after the addition of ISC to the cells, gradually increased with time, and then leveled off. Cytolytic activity of M-Ad ISC is specific for M-Ad, since ISC do not lyse mouse embryonic cells infected with human adenovirus type 12 and vice versa. Kinetic study of the development of cell-mediated immunity to M-Ad assayed by 51Cr release showed that cytolytic activity of ISC in infected mice became detectable 4 days postinfection, reached its peak level about 7 to 10 days postinfection, and fell to undetectable levels about 10 days thereafter. This is consistent with the data obtained by inhibition of intracellular viral antigen synthesis or by the macrophage migration inhibition test in our prevous reports.

Entities:  

Mesh:

Year:  1978        PMID: 208968      PMCID: PMC421540          DOI: 10.1128/iai.20.1.1-5.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Mechanism of induction of cell-mediated immunity to virus infections: in vitro inhibition of intracellular multiplication of mouse adenovirus by immune spleen cells.

Authors:  C Hamada; H Uetake
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Cellular immune response to viral infection: in vitro studies of lymphocytes from mice infected with Sindbis virus.

Authors:  D E Griffin; R T Johnson
Journal:  Cell Immunol       Date:  1973-12       Impact factor: 4.868

3.  Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. II. In vitro methods for the measurement and qualitation of the immune response.

Authors:  W H Adler; S G Rabinowitz
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

4.  The characteristics of lymphocyte tritiated thymidine incorporation in response to mumps virus.

Authors:  K A Smith; L Chess; M R Mardiney
Journal:  Cell Immunol       Date:  1972-12       Impact factor: 4.868

5.  The cell-mediated immune response to ectromelia virus infection. I. Kinetics and characteristics of the primary effector T cell response in vivo.

Authors:  R V Blanden; I D Gardner
Journal:  Cell Immunol       Date:  1976-03-15       Impact factor: 4.868

6.  Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity.

Authors:  K T Brunner; J Mauel; H Rudolf; B Chapuis
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

7.  Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.

Authors:  U Koszinowski; R Thomssen
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

8.  Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

9.  Virus-Induced Specific Cell Surface Antigen(s) on Mouse Adenovirus-Infected Cells.

Authors:  T Inada; H Uetake
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

10.  Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice.

Authors:  R M Bhatnagar; J B Zabriskie; A R Rausen
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Murine adenoviruses: tools for studying adenovirus pathogenesis in a natural host.

Authors:  Silvio Hemmi; Katherine R Spindler
Journal:  FEBS Lett       Date:  2019-12-06       Impact factor: 4.124

2.  Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice.

Authors:  Megan C Procario; Rachael E Levine; Mary K McCarthy; Eunnie Kim; Lingqiao Zhu; Cheong-Hee Chang; Marc B Hershenson; Jason B Weinberg
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  Nature and specificity of effector cells in cell-mediated cytolysis of mouse adenovirus-infected cells.

Authors:  T Inada; H Uetake
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

4.  Lack of effect of mouse adenovirus type 1 infection on cell surface expression of major histocompatibility complex class I antigens.

Authors:  S C Kring; K R Spindler
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice.

Authors:  K Smith; C C Brown; K R Spindler
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  T cells cause acute immunopathology and are required for long-term survival in mouse adenovirus type 1-induced encephalomyelitis.

Authors:  Martin L Moore; Corrie C Brown; Katherine R Spindler
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 7.  Potential detrimental effects of rodent viral infections on long-term experiments.

Authors:  G Lussier
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.